Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00809510
What this trial is testing

The Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

Who this might be right for
Alzheimer's Disease
Abbott 63
Not applicableUnknownNCT02778581
What this trial is testing

Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment

Who this might be right for
Cognitive ImpairmentsAlzheimer Disease
Team Foods Colombia S.A. 110
Testing effectiveness (Phase 2)Study completedNCT02279511
What this trial is testing

ATP in Alzheimer Disease

Who this might be right for
Alzheimer's Disease
Sara Varea 20
Not applicableLooking for participantsNCT06923007
What this trial is testing

Alzheimer's Disease Treated With Vagus Nerve Stimulation

Who this might be right for
Alzheimer Disease (AD)
Beijing Municipal Administration of Hospitals 74
Not applicableEnded earlyNCT01001637
What this trial is testing

Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Jaslok Hospital and Research Centre 26
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Testing effectiveness (Phase 2)Study completedNCT00151398
What this trial is testing

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 229
Testing effectiveness (Phase 2)Study completedNCT00930059
What this trial is testing

PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 191
Not applicableStudy completedNCT00889603
What this trial is testing

Non-Interventional Study With Aricept® Evess

Who this might be right for
Alzheimer's DiseaseVascular Dementia
Pfizer 370
Large-scale testing (Phase 3)Study completedNCT01689246
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 891
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Testing effectiveness (Phase 2)Study completedNCT00153010
What this trial is testing

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 430
Large-scale testing (Phase 3)Study completedNCT04994483
What this trial is testing

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 804
Not applicableNot Yet RecruitingNCT06978946
What this trial is testing

Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients

Who this might be right for
Alzheimer DiseaseLewy Body Dementia (LBD)Frontotemporal Dementia (FTD)+2 more
RenJi Hospital 85
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Large-scale testing (Phase 3)Study completedNCT01955161
What this trial is testing

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 933
Testing effectiveness (Phase 2)Looking for participantsNCT06995573
What this trial is testing

Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
NSC-Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT06721156
What this trial is testing

Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Who this might be right for
Alzheimer DiseaseDementia
Merck Sharp & Dohme LLC 369
Early research (Phase 1)Study completedNCT00766363
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System Diseases
FORUM Pharmaceuticals Inc 49
Testing effectiveness (Phase 2)UnknownNCT02672306
What this trial is testing

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
South China Research Center for Stem Cell and Regenerative Medicine 16
Next Page